The concomitant lack of ER, PR, and HER2 defines Triple- Negative Breast Cancer (TNBC), a subtype that comprises 15-20% of all BC, highly prevalent in women younger than 40, Black, or with BRCA1 gene mutation, and represents the most challenging BC to be treated. Here, BRCA1 is linked to breast cancer.